지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.9
- 수록면
- 1,900 - 1,908 (9page)
- DOI
- 10.1038/s12276-024-01301-3
이용수
초록· 키워드
오류제보하기
IL-2 therapy, which enhances the function of CD8 + T cells, was initially employed as the cornerstone of immunotherapy against cancer. However, the impact of this therapy extends beyond CD8 + T cells to cells expressing IL-2R, such as endothelial cells and regulatory T cells (Tregs), resulting in various side effects. Consequently, IL-2 therapy has taken a step back from the forefront of treatment. Immune checkpoint inhibitors (ICIs), such as anti-PD-1/PD-L1 antibodies and CTLA-4 antibodies, are used because of their durable therapeutic responses and the reduced incidence of side effects. Nevertheless, only a small fraction of cancer patients respond to ICIs, and research on IL-2 as a combination treatment to improve the efficacy of these ICIs is ongoing. To mitigate side effects, efforts have focused on developing IL-2 variants that do not strongly bind to cells expressing IL-2Rα and favor signaling through IL-2Rβγ. However, recent studies have suggested that, in the context of persistent antigen stimulation models, effective stimulation of antigen-specific exhausted CD8 + T cells in combination with PD-1 inhibitors requires either 1) binding to IL-2Rα or 2) delivery via a fusion with PD-1. This review explores the historical context of IL-2 as an immunotherapeutic agent and discusses future directions for its use in cancer immunotherapy.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
IL-30† (IL-27A): a familiar stranger in immunity, inflammation, and cancer
Experimental and Molecular Medicine
2021 .05
-
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
BMB Reports
2021 .01
-
IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation
Experimental and Molecular Medicine
2017 .01
-
A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathy
Experimental and Molecular Medicine
2024 .08
-
IL-33 and IL-33-derived DC-based tumor immunotherapy
Experimental and Molecular Medicine
2024 .06
-
Interleukin-32: Frenemy in cancer?
BMB Reports
2019 .01
-
Interleukin-2/antibody complex expanding Foxp3＋ regulatory T cells exacerbates Th2-mediated allergic airway inflammation
BMB Reports
2019 .01
-
Development of Human PD-1 Specific Repebody for Cancer Immunotherapy
한국생물공학회 학술대회
2019 .04
-
Locus of (IL-9) control: IL9 epigenetic regulation in cellular function and human disease
Experimental and Molecular Medicine
2024 .06
-
Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells
한국환경기술학회지
2017 .01
-
IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
Experimental and Molecular Medicine
2016 .01
-
Cancer immunotherapy: special issue of BMB Reports in 2021
BMB Reports
2021 .01
-
Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells
BMB Reports
2019 .01
-
Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40hiCD5+ regulatory B cells in vitro and in vivo
BMB Reports
2015 .01
-
Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway
Experimental and Molecular Medicine
2020 .12
-
Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity
BMB Reports
2021 .10
-
Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy
Experimental and Molecular Medicine
2017 .01
-
Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion
Experimental and Molecular Medicine
2021 .02
-
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Experimental and Molecular Medicine
2019 .01
-
Strategy for Enhancing the Life Span of Natural Killer Cells Using Mechanical Stimulation
한국생물공학회 학술대회
2021 .04
최근 본 자료
댓글(0)
0